A MOUSE CDC25 HOMOLOG IS DIFFERENTIALLY AND DEVELOPMENTALLY EXPRESSED

被引:69
|
作者
KAKIZUKA, A
SEBASTIAN, B
BORGMEYER, U
HERMANSBORGMEYER, I
BOLADO, J
HUNTER, T
HOEKSTRA, MF
EVANS, RM
机构
[1] UNIV CALIF SAN DIEGO, LA JOLLA, CA 92093 USA
[2] SALK INST BIOL STUDIES, MOLEC BIOL & VIROL LAB, LA JOLLA, CA 92037 USA
[3] SALK INST BIOL STUDIES, HOWARD HUGHES MED INST, LA JOLLA, CA 92037 USA
关键词
CDC25M2; MOUSE; DEVELOPMENTAL EXPRESSION; CELL-CYCLE-DEPENDENT EXPRESSION; PHOSPHATASE;
D O I
10.1101/gad.6.4.578
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The timing and activation of the p34cdc2 kinase in mammals is associated with dephosphorylation of phosphotyrosine and phosphothreonine residues on the p34cdc2 kinase. For fission yeast, the timing of mitosis is regulated by cyclic accumulation of cdc25, which promotes dephosphorylation of p34cdc2 and concomitant protein kinase activation. We report the identification and characterization of a structural and functional mouse homolog, Cdc25M2, of the cdc25 phosphatase. Cdc25M2 shows high sequence identity to the previously reported human homolog cdc25Hu2. Cdc25M2 can functionally complement for a Schizosaccharomyces pombe cdc25ts mutation, and when expressed in Escherichia coli and purified, Cdc25M2 is an active phosphatase. cdc25M2 mRNA shows variation in expression in different tissues in the mouse embryo and is expressed in a developmental and cell-cycle-dependent fashion. We suggest that the expression and accumulation of the cdc25 mitotic inducer may play a critical role in the regulation of mouse development.
引用
收藏
页码:578 / 590
页数:13
相关论文
共 50 条
  • [21] Redox regulation of the Cdc25 phosphatases
    Rudolph, J
    ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (5-6) : 761 - 767
  • [22] Cdc25 inhibitors in melanoma cells
    Capasso, A.
    Cerchia, C.
    Di Giovanni, C.
    Granato, G.
    Bertoni, A.
    Albano, F.
    De Vendittis, E.
    Ruocco, M. R.
    Lavecchia, A.
    FEBS JOURNAL, 2014, 281 : 66 - 67
  • [23] CDC25 phosphatases and checkpoint controls
    Draetta, G
    Donzelli, M
    Squatrito, M
    Ganoth, D
    Hershko, A
    Pagano, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S116 - S116
  • [24] Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones
    Sohn, J
    Kiburz, B
    Li, ZT
    Deng, L
    Safi, A
    Pirrung, MC
    Rudolph, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (13) : 2580 - 2588
  • [25] THE MINIMAL ACTIVE DOMAIN OF THE MOUSE RAS EXCHANGE FACTOR CDC25(MM)
    COCCETTI, P
    MAURI, I
    ALBERGHINA, L
    MARTEGANI, E
    PARMEGGIANI, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (01) : 253 - 259
  • [26] Cdc25 phosphatases: Structure, specificity, and mechanism
    Rudolph, Johannes
    BIOCHEMISTRY, 2007, 46 (12) : 3595 - 3604
  • [27] Studies on menadione as an inhibitor of the cdc25 phosphatase
    Ham, SW
    Park, HJ
    Lim, DH
    BIOORGANIC CHEMISTRY, 1997, 25 (01) : 33 - 36
  • [28] Cdc25 as a potential target of anticancer agents
    Eckstein, JW
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (02) : 149 - 156
  • [29] Characterization of the Cdc25 phosphatase in Pneumocystis carinii
    Gustafson, MP
    Limper, AH
    Leof, EB
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1999, 46 (05) : 129S - 129S
  • [30] Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies
    Sur, Swastika
    Agrawal, Devendra K.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2016, 416 (1-2) : 33 - 46